CODX - CIK 0001692415
Co-Diagnostics, Inc. trades as CODX. In its fiscal 2025 annual report the company posted revenue of $622.49K, down 84.1% from the prior year and net income of -$46.90M. This page tracks Co-Diagnostics, Inc. through 355 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 8 fiscal years Co-Diagnostics, Inc.'s revenue grew from $7.66K to $622.49K, a compound annual growth rate of 73.3%. Net profit margin expanded from -90827.9% to -7533.6% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Major company event | 8-K | 2026-05-21 |
The largest companies sharing Co-Diagnostics, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
Co-Diagnostics, Inc. reported revenue of $622.49K for fiscal year 2025, a decrease of 84.1% year over year.
In its latest fiscal year Co-Diagnostics, Inc. reported a net loss of $46.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.